MPM Oncology Impact Management as of March 31, 2020
Portfolio Holdings for MPM Oncology Impact Management
MPM Oncology Impact Management holds 10 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Harpoon Therapeutics | 27.6 | $45M | 3.9M | 11.58 | |
| Epizyme | 22.1 | $36M | 2.3M | 15.51 | |
| Tcr2 Therapeutics Inc cs | 15.9 | $26M | 3.4M | 7.74 | |
| G1 Therapeutics | 9.6 | $16M | 1.4M | 11.02 | |
| Turning Point Therapeutics I | 8.4 | $14M | 309k | 44.66 | |
| Mei Pharma | 6.1 | $10M | 6.3M | 1.61 | |
| Y Mabs Therapeutics (YMAB) | 5.4 | $8.8M | 337k | 26.10 | |
| Cytomx Therapeutics (CTMX) | 4.0 | $6.6M | 855k | 7.67 | |
| Sunesis Pharmaceuticals Inc Ne | 0.7 | $1.2M | 2.8M | 0.41 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.1 | $238k | 40k | 5.99 |
